CS100/CS100i Intra-Aortic Balloon Pump, CS300 Intra-Aortic Balloon Pump

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG ADMINISTRATION' in blue text. October 12, 2017 Datascope Corp. Helder Sousa Manager, Regulatory Affairs 1300 MacArthur Blvd. Mahwah, New Jersey 07430 Re: K172305 Trade/Device Name: CS100/CS100i Intra-Aortic Balloon Pump, CS300 Intra-Aortic Balloon Pump Regulation Number: 21 CFR 870.3535 Regulation Name: Intra-aortic balloon and control system Regulatory Class: Class II Product Code: DSP Dated: September 22, 2017 Received: September 25, 2017 Dear Helder Sousa: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevicesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely, Nicole G. Ibrahim -S for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications For Use 510(k) Number (if known): K172305 Device Name: CS100/CS100i and CS300 Intra-Aortic Balloon Pumps - The CS100/CS100i and CS300 Intra-Aortic Balloon Pumps are Indications For Use: indicated for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure. Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) {3}------------------------------------------------ ### CS100/CS100i AND CS300 INTRA-AORTIC BALLOON PUMPS 510(k) Summary Prepared in accordance with 21 CFR Part 807.92 ### 510(k) Number: K172305 ### GENERAL INFORMATION Submitter's name and address: Datascope Corp. 1300 MacArthur Blvd. Mahwah, NJ 07430 Helder A. Sousa Contact person and telephone number: Manager, Regulatory Affairs Phone: (973) 709-7465 Fax: (973) 629-1325 Email: helder.sousa@getinge.com Date prepared: July 28, 2017 #### DEVICE INFORMATION: | Trade Name: | CS100/CS100i and CS300 Intra-Aortic Balloon Pump | |----------------------|--------------------------------------------------| | Common/Generic Name: | Intra-Aortic Balloon Pump (IABP) | | Classification Name: | Intra-Aortic Balloon and control system | | Regulation Number: | 21 CFR 870.3535 | | Regulatory Class: | Class II | | Product Code: | DSP | ### PREDICATE DEVICE INFORMATION: CS100/CS100i and CS300 Intra-Aortic Balloon Pumps (K031636 and K063525) #### DEVICE DESCRIPTION: The CS100/CS100i and CS300 Intra-Aortic Balloon Pumps (IABPs) are cardiac assist devices. The IABP supports the heart's left ventricle by increasing coronary perfusion and reducing left ventricular work. Coronary perfusion is increased by augmenting blood pressure during the diastolic phase of the cardiac cycle. This increase in aortic pressure promotes more blood flow through the coronary arteries. Left ventricular work is reduced by decreasing aortic end-diastolic pressure and reducing resistance to ventricular ejection, resulting in a decrease in blood pressure during the systolic phase of the cardiac cycle. {4}------------------------------------------------ These beneficial effects are caused by the inflation and deflation of an intra-aortic balloon (IAB) in the patient's descending aorta. The balloon's inflation and deflation must be properly synchronized with the cardiac cycle. IAB inflation is initiated at the onset of diastole at the dicrotic notch and remains inflated through diastole. The IAB is then deflated at, or just prior to, the onset of systole and the balloon remains deflated throughout systole. Hence, the therapy is also referred to as counterpulsation. This is the same intended use as other IABPs. # INDICATIONS FOR USE: The CS100/CS100i and CS300 Intra-Aortic Balloon Pumps are indicated for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure. # COMPARISON OF TECHNOLOGICAL CHARACTERISTICS TO PREDICATES: The modified CS100/CS100i and CS300 Intra-Aortic Balloon Pumps are substantially equivalent to the CS100/CS100i and CS300 Intra-Aortic Balloon Pumps (K031636 and K063525). The changes essentially consist essentially consist of a revised blood detection software function to implement an automatic repeat of the autofill process without the need for operator intervention or system shutdown while continuing to use the optical blood detection sensor to monitor for blood in the catheter. # PERFORMANCE DATA: The results of the tests conducted demonstrate that the modified CS100/CS100i and CS300 Intra-Aortic Balloon Pumps perform as intended. Datascope Corp. development process required that the following activities be completed during the development of the modified CS100/CS100i and CS300 Intra-Aortic Balloon Pumps: - Requirements specification review ● - . Performance testing - . Design verification and validation # CLINICAL TESTS: There was no clinical evaluation of the modified device. ### Conclusion: Based upon the information submitted in this Special 510(k) premarket notification, the modified device is substantially equivalent to the currently marketed CS100/CS100i andCS300 Intra-Aortic Balloon Pumps. The CS100/CS100i and CS300 IABPs with the revised software is similar to the predicate device in the intended use and the fundamental scientific technology of the device. The design verification and validation testing established that the CS100/CS100i and CS300 IABPs with the revised software performs as well as the predicate device.